Lost password ?
Adwya
Generics making some good progress...
- "- A modest 2.58% yoy growth in Q1 2019 revenues, mainly pulled up by a rise in generics sales (23.5% yoy) of which the contribution to total revenues remained stable. - The company’s gross ..."
Executive summary
Conflicts of Interest
Pages 38
Language English
Publish on April 23, 2019
€ 500
VAT Exl.
You may also be interested by these reports :
FIND A REPORT
SIMPLE, TO THE POINT IDEA GENERATION
Each company is researched in depth using a structured, robust and transparent process. Valuations are disciplined and dispassionate.
AlphaMena allows you to compare stocks along a wide range of parameters be it by sector, by geography or an array of investment themes.
Our reports include actuarial as well as off balance-sheet data and governance metrics.
Priority is given to idea generation through quick, to the point, answers by means of browsing from one idea to the next.